Successful implementation of a pediatric sedation protocol for mechanically ventilated patients

Department of Pediatrics, Seattle Children's Hospital University of Washington, Seattle, WA, USA.
Critical care medicine (Impact Factor: 6.15). 04/2011; 39(4):683-8. DOI: 10.1097/CCM.0b013e318206cebf
Source: PubMed

ABSTRACT To evaluate the effect of a nursing-driven sedation protocol for mechanically ventilated pediatric patients on duration of use of analgesic and sedative medications. We hypothesized that a protocol would decrease length of sedation use and decrease days of mechanical ventilation and length of stay.
Retrospective cohort study with historical controls.
Thirty-one-bed tertiary care, medical-surgical-cardiac pediatric intensive care unit in a metropolitan university-affiliated children's hospital.
Children requiring mechanical ventilation longer than 48 hrs not meeting exclusion criteria.
Before protocol implementation, sedation was managed per individual physician orders. During the intervention period, analgesia and sedation were managed by nurses following an algorithm-based sedation protocol based on a comfort score.
The observation group included consecutive patients admitted during the 12-month period before protocol education and implementation (n = 153). The intervention group included patients admitted during the 12 months following protocol implementation (n = 166). The median duration of total sedation days (intravenous plus enteral) was 7 days for the observation period and 5 days for the intervention period (p = .026). Specifically, the median duration of morphine infusion was 6 days for the observation period and 5 days for the intervention period (p = .015), whereas the median duration of lorazepam infusion was 2 days for the observation period and 0 days for the intervention period. After adjusting for severity of illness with the pediatric risk of mortality III (PRISM III) score, the Cox proportional hazards regression analysis demonstrated that at any point in time, patients in the intervention group were 23% more likely to be off all sedation (heart rate 0.77, p = .020). Additionally, the intervention group tended to be associated with fewer days of mechanical ventilation (heart rate 0.81, p = .060) and decreased pediatric intensive care unit length of stay (heart rate 0.81, p = .058), although these associations did not quite reach statistical significance.
A pediatric sedation protocol can significantly decrease days of benzodiazepine and opiate administration, which may improve pediatric intensive care unit resource utilization.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The alleviation of pain and anxiety is an important component of caring for the critically ill child. Sedation and analgesia regimens are utilized as adjuncts to procedures, facilitate mechanical ventilation, and assist with management of the critically ill child. Although sedation regimens have been used extensively across intensive care units, the data are lacking as to the best drugs, dosing, regimens, and short- and long-term safety profiles for use in the pediatric population. Sedation regimens continue to be a challenging aspect of the care of the critically ill child, and they have been associated with significant morbidity in this population. The following chapter will discuss the sedative use in the intensive care unit, morbidity associated with sedatives and analgesics, and the importance of establishing sedation and analgesia algorithms to reduce morbidity and mortality.
    Seminars in Pediatric Surgery 11/2014; 24(1). DOI:10.1053/j.sempedsurg.2014.11.011 · 1.94 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective:To test whether implementing a nursing-driven comfort protocol standardizes morphine use in one neonatal intensive care unit (NICU) and to examine how non-standard morphine (N-SM) relates to days of ventilation, days of total parenteral nutrition (TPN) and length of stay (LOS).Study Design:This was a retrospective/prospective observational study using pharmacy records, medical records, and an outcomes database. Comfort protocol implementation began February 2011 and was applied to preterm, ventilated neonates <1500 grams. Pre- and post-implementation proportions of N-SM days were compared using the binomial test. A percent 'P'-chart spanning 30 quarters was constructed with statistical-process control analysis. Multivariable linear regression adjusting for acuity assessed the relationship between N-SM use and days of ventilation, TPN and LOS.Result:Hundred and thirty-four patients met inclusion criteria, 116 prior to and 18 after implementation. The proportion of patients given N-SM for one or more days decreased from 59 to 35% after protocol implementation (P=0.017). A 9-month period of decreased N-SM days was observed after protocol implementation. Controlling for acuity, each additional day of N-SM use was associated with 0.47 more days of ventilation (95% confidence interval (CI): 0.26-0.69, P<0.001) and 0.52 more days of TPN (95% CI: 0.35-0.68, P<0.001). Exposure to N-SM was associated with 17 additional days of hospitalization (P=0.009, 95% CI: 4.5-30).Conclusion:Implementing a nursing-driven comfort protocol significantly reduced N-SM use. N-SM in the NICU is negatively associated with key clinical outcomes. Testing similar protocols in other settings is warranted.Journal of Perinatology advance online publication, 24 July 2014; doi:10.1038/jp.2014.131.
    Journal of perinatology: official journal of the California Perinatal Association 07/2014; DOI:10.1038/jp.2014.131 · 2.35 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective: To determine whether long-term dexmedetomidine dosing is associated with lower opioid and benzodiazepine use without risk of significant hemodynamic changes and/or withdrawal. Design: Retrospective, observational study. Setting: PICU, cardiovascular ICU, and neonatal ICU in a single, tertiary care, academic children's hospital. Subjects: We included all patients less than or equal to 21 years old, who received dexmedetomidine for greater than or equal to 72 hours from December 2008 to December 2010 resulting in a 98-subject cohort. Interventions: None. Measurement and Main Results: The median duration of dexmedetomidine use was 141 hours. A decrease in systolic blood pressure and heart rate was seen after initiation of dexmedetomidine. After dexmedetomidine was discontinued, systolic blood pressure was statistically significantly higher than baseline. Similarly, heart rate showed a significant increase from baseline following discontinuation of dexmedetomidine. Starting dexmedetomidine was not associated with a significant difference in the dosing of opiates or benzodiazepines. Comfort scores were significantly lower at 2 and 72 hours of dexmedetomidine infusion. After stopping dexmedetomidine, the comfort score for patients at 1 hour was statistically higher than for patients at cessation of the infusion. Thirty percent of patients who were taken off dexmedetomidine, whether weaned or abruptly stopped, had withdrawal symptoms and scores recorded with agitation, tremor, and decreased sleep being most prominent. Conclusions: Hemodynamic effects of dexmedetomidine did not limit long-term use in this diverse population. After the addition of dexmedetomidine, opioid and benzodiazepine doses did not significantly escalate, and patients were more comfortable as evidenced by decreasing comfort scores. Withdrawal from dexmedetomidine may be an issue and manifests as agitation, tremors, and decreased sleep.
    Pediatric Critical Care Medicine 07/2014; 15(8). DOI:10.1097/PCC.0000000000000200 · 2.33 Impact Factor

Full-text (2 Sources)

Available from
May 16, 2014